These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. How fatty acids bind to proteins: the inside story from protein structures. Hamilton JA Prostaglandins Leukot Essent Fatty Acids; 2002; 67(2-3):65-72. PubMed ID: 12324222 [TBL] [Abstract][Full Text] [Related]
48. Peroxisome Proliferator-Activated Receptors Protect against Apoptosis via 14-3-3. Wu KK PPAR Res; 2010; 2010():. PubMed ID: 20862376 [TBL] [Abstract][Full Text] [Related]
49. Computational design and experimental confirmation of conformationally constrained peptides to compete with coactivators for pediatric PPAR[Formula: see text] by minimizing indirect readout effect. Gao C; Zhao X; Fan J J Bioinform Comput Biol; 2022 Oct; 20(5):2250020. PubMed ID: 36098714 [TBL] [Abstract][Full Text] [Related]
50. Energy balance: a new role for PPARalpha. Rosen ED Curr Biol; 2003 Dec; 13(24):R961-3. PubMed ID: 14680654 [No Abstract] [Full Text] [Related]
51. Ablation of Fatty Acid Transport Protein-4 Enhances Cone Survival, M-cone Vision, and Synthesis of Cone-Tropic 9- Li S; Jin M J Neurosci; 2024 Jul; 44(27):. PubMed ID: 38811164 [TBL] [Abstract][Full Text] [Related]
52. Role of fatty acid transport protein 4 in metabolic tissues: insights into obesity and fatty liver disease. Li H; Herrmann T; Seeßle J; Liebisch G; Merle U; Stremmel W; Chamulitrat W Biosci Rep; 2022 Jun; 42(6):. PubMed ID: 35583196 [TBL] [Abstract][Full Text] [Related]
53. Sirtuin 3-mediated deacetylation of acyl-CoA synthetase family member 3 by protocatechuic acid attenuates non-alcoholic fatty liver disease. Sun R; Kang X; Zhao Y; Wang Z; Wang R; Fu R; Li Y; Hu Y; Wang Z; Shan W; Zhou J; Tian X; Yao J Br J Pharmacol; 2020 Sep; 177(18):4166-4180. PubMed ID: 32520409 [TBL] [Abstract][Full Text] [Related]
54. Integrated physiology and systems biology of PPARα. Kersten S Mol Metab; 2014 Jul; 3(4):354-71. PubMed ID: 24944896 [TBL] [Abstract][Full Text] [Related]
55. Proline- and acidic amino acid-rich basic leucine zipper proteins modulate peroxisome proliferator-activated receptor alpha (PPARalpha) activity. Gachon F; Leuenberger N; Claudel T; Gos P; Jouffe C; Fleury Olela F; de Mollerat du Jeu X; Wahli W; Schibler U Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4794-9. PubMed ID: 21383142 [TBL] [Abstract][Full Text] [Related]
56. Molecular Mechanisms and Genome-Wide Aspects of PPAR Subtype Specific Transactivation. Bugge A; Mandrup S PPAR Res; 2010; 2010():. PubMed ID: 20862367 [TBL] [Abstract][Full Text] [Related]
57. Liver fatty acid binding protein gene ablation enhances age-dependent weight gain in male mice. Martin GG; Atshaves BP; McIntosh AL; Payne HR; Mackie JT; Kier AB; Schroeder F Mol Cell Biochem; 2009 Apr; 324(1-2):101-15. PubMed ID: 19104910 [TBL] [Abstract][Full Text] [Related]
58. Downregulation of PPARs and SREBP by acyl-CoA-binding protein overexpression in transgenic rats. Oikari S; Ahtialansaari T; Heinonen MV; Mauriala T; Auriola S; Kiehne K; Fölsch UR; Jänne J; Alhonen L; Herzig KH Pflugers Arch; 2008 May; 456(2):369-77. PubMed ID: 18157544 [TBL] [Abstract][Full Text] [Related]
59. Stability of fatty acyl-coenzyme A thioester ligands of hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha. Schroeder F; Huang H; Hostetler HA; Petrescu AD; Hertz R; Bar-Tana J; Kier AB Lipids; 2005 Jun; 40(6):559-68. PubMed ID: 16149734 [TBL] [Abstract][Full Text] [Related]
60. Role of adipocyte lipid-binding protein (ALBP) and acyl-coA binding protein (ACBP) in PPAR-mediated transactivation. Helledie T; Jørgensen C; Antonius M; Krogsdam AM; Kratchmarova I; Kristiansen K; Mandrup S Mol Cell Biochem; 2002 Oct; 239(1-2):157-64. PubMed ID: 12479581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]